Literature DB >> 15896957

Structure-activity relationship of N-methyl-bisindolylmaleimide derivatives as cell death inhibitors.

Miho Katoh1, Kosuke Dodo, Mikako Fujita, Mikiko Sodeoka.   

Abstract

A series of N-methyl-bisindolylmaleimide derivatives was synthesized and evaluated as cell death inhibitors. N-Methyl-2-[1-(3-aminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl)maleimide (21) was the most potent inhibitor of H2O2-induced necrotic death of human leukemia HL60 cells among them.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15896957     DOI: 10.1016/j.bmcl.2005.04.015

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Chemo- and diastereoselectivities in the electrochemical reduction of maleimides.

Authors:  Kathryn Rix; Geoffrey H Kelsall; Klaus Hellgardt; King Kuok Mimi Hii
Journal:  ChemSusChem       Date:  2015-01-08       Impact factor: 8.928

2.  Identification of Bisindolylmaleimide IX as a potential agent to treat drug-resistant BCR-ABL positive leukemia.

Authors:  Xin Zhang; Deyong Jia; Junping Ao; Huijuan Liu; Yi Zang; Mohammad Azam; Samy L Habib; Jia Li; Xinsen Ruan; Hao Jia; Xueying Wang; Baojie Li
Journal:  Oncotarget       Date:  2016-10-25

3.  Indolylmaleimide Derivative IM-17 Shows Cardioprotective Effects in Ischemia-Reperfusion Injury.

Authors:  Kosuke Dodo; Tadashi Shimizu; Jun Sasamori; Kazuyuki Aihara; Naoki Terayama; Shuhei Nakao; Katsuya Iuchi; Masahiro Takahashi; Mikiko Sodeoka
Journal:  ACS Med Chem Lett       Date:  2018-01-29       Impact factor: 4.345

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.